33M+
MA Enrollees (2024)
Medicare Advantage now covers more than 33 million beneficiaries, over half of all Medicare eligibles, making disenrollment procedure a high-volume compliance requirement for every participating plan.
CMS MA Enrollment Data, 2024
6
Permissible Involuntary Grounds
42 CFR 422.74 lists exactly six grounds for plan-initiated disenrollment. Any removal outside these grounds, regardless of operational justification, is a regulatory violation subject to CMS sanctions.
42 CFR 422.74
63
Day Gap Before LEP Applies
Members who lose Part D coverage at MAPD disenrollment face a permanent late enrollment penalty if the drug coverage gap exceeds 63 days. Most plan disenrollment workflows fail to communicate this risk clearly.
42 CFR Part 423, Subpart B
Insight Summary
- Medicare Advantage now covers more than 33 million beneficiaries (2024), making disenrollment procedure one of the highest-volume compliance obligations in the managed care sector.
- CMS monitors both voluntary and involuntary disenrollment rates as part of ongoing plan performance oversight, directly linking disenrollment patterns to Star Ratings, quality bonus eligibility, and audit targeting.
- The most common compliance failure is not using a prohibited ground, it is using a valid ground without the required procedural documentation: notice deficiencies, missing CMS approval for disruptive behaviour cases, and incomplete file records.
- The Part D coverage gap at MAPD disenrollment is the most systematically underestimated member risk: a gap exceeding 63 days triggers a permanent late enrollment penalty that accumulates for the rest of the member’s life.
- CMS Civil Monetary Penalties for disenrollment violations can reach $25,000 per member per violation, with additional penalties per day for ongoing non-compliance, compounding rapidly in high-volume disenrollment periods.
- Plans that treat disenrollment monitoring as a standing compliance programme component, not a reactive audit response, consistently outperform peers on Star Ratings disenrollment-related measures.
Key Insight
The compliance risk in MAPD disenrollment is not primarily in what ground is cited, it is in the documentation and process that surrounds it. CMS enforcement actions routinely cite procedurally defective disenrollments on otherwise valid grounds, because the notice was incomplete, the CMS approval was not obtained, or the file record was insufficient to withstand audit review.
The implication for compliance leaders: a disenrollment programme that focuses only on whether the ground is permissible is answering the wrong question. The question CMS auditors ask is whether the process, from identification through notification through effective date, was executed correctly and can be demonstrated from the file.
What the Compliance Data Shows
CMS publishes plan-level disenrollment data through the Medicare Advantage plan performance reporting framework. This data informs Star Ratings, triggers audit selection, and is used in CMS’s ongoing oversight of plan compliance with beneficiary rights requirements. The patterns that emerge from this data are not random, they reflect structural weaknesses in how plans design and operate their disenrollment programmes.
Finding 1: Disenrollment rates directly affect Star Ratings and quality bonus eligibility
CMS incorporates member experience measures, including disenrollment patterns, into the Star Ratings framework that determines quality bonus payments. Plans with high voluntary disenrollment rates relative to their peer group signal member dissatisfaction, a factor CMS uses in audit selection and that directly reduces Star Rating scores. A plan that loses one quality bonus star loses approximately 5% of its benchmark payment, which for a plan with $1 billion in revenue represents $50 million in annual quality bonus reduction. Disenrollment monitoring is therefore not just a compliance obligation, it is a financial performance issue. What this means for compliance leaders: voluntary disenrollment rates must be tracked monthly against CMS-published peer benchmarks, not just reviewed annually during audit season.
Finding 2: CMS Civil Monetary Penalties for disenrollment violations compound rapidly
Under 42 CFR 422.752, CMS may impose Civil Monetary Penalties (CMPs) of up to $25,000 per member for disenrollment that violates a member’s rights, plus up to $10,000 per day for ongoing non-compliance. In a plan with hundreds of disenrollment transactions per month, a systematic procedural deficiency, such as consistently defective notice language or failure to obtain required CMS approval for disruptive behaviour cases, compounds quickly across multiple members. The more important finding is not the maximum penalty figure: it is that CMS uses a per-member calculation, meaning every improperly processed disenrollment is a separate penalty event. For compliance leaders, this means that a deficiency affecting 50 disenrollments at $25,000 each represents $1.25 million in potential CMP exposure before per-day sanctions apply.
Finding 3: The Part D coverage gap is the most underestimated member harm at disenrollment
When a beneficiary disenrolls from a MAPD plan, integrated Part D coverage ends at the same moment as Part C coverage. Members who do not promptly enroll in a standalone PDP or another MAPD face a drug coverage gap. Under 42 CFR Part 423, a gap exceeding 63 days triggers a late enrollment penalty calculated as 1% of the national base beneficiary premium for every month without coverage, a penalty that is permanent and accumulates for the rest of the member’s life. What this suggests is that plan disenrollment communications are systematically failing a material subset of members: those who disenrol without understanding that their drug coverage ends simultaneously and that the window to avoid a permanent financial penalty is 63 days.
| Dimension | Voluntary Disenrollment | Involuntary Disenrollment |
|---|---|---|
| Who initiates | Member | MA organisation (or CMS, for contract terminations) |
| Governing regulation | 42 CFR 422.62 | 42 CFR 422.74 |
| Timing constraint | AEP, OEP, or qualifying SEP only | When permitted ground is met; advance written notice required |
| Part D impact | Part D ends simultaneously; SEP to join PDP may apply | Part D ends simultaneously; involuntary loss SEP typically applies |
| Member appeal right | No, member-initiated | Yes, member may appeal before effective date |
| CMP exposure | If plan restricts or delays a valid election | Up to $25,000 per member per violation; $10,000 per day ongoing |
What Is Driving the Compliance Gap
Disenrollment violations are not primarily driven by plans intentionally citing prohibited grounds. The pattern CMS finds in audits is more structural: the compliance failure occurs in the operational execution of otherwise valid disenrollments. Three factors consistently produce the documentation and process failures that generate audit findings.
Disenrollment is operationally separated from compliance review
In many plans, disenrollment processing is handled by enrollment operations teams under volume and timeliness pressures, with compliance review occurring after the fact rather than as a pre-execution gate. This structure produces an environment where individual transactions are processed correctly in isolation but systemic patterns, a notice template that consistently omits required elements, a ground being applied without required documentation, are not caught until a CMS audit surfaces them. The practical implication is that compliance programme design must treat disenrollment as a front-end compliance function, not a back-end audit subject.
Staff training on prohibited grounds is clearer than training on required procedures
Most plans train disenrollment staff on what the six permissible grounds are. Fewer plans train staff with equal specificity on the procedural requirements: what documentation is required before taking action, what the notice must contain, when CMS approval must be obtained before the effective date, and what the file must contain to withstand audit review. The pattern becomes clearer when examining grievance and appeal data: the most common complaint category from members who have been involuntarily disenrolled is not that the ground was wrong, it is that they did not receive proper written notice or did not understand their appeal rights.
Part D communication is treated as a downstream concern rather than a disenrollment obligation
Plans that communicate Part D impact at the point of disenrollment are fulfilling a regulatory obligation under the integrated product framework, not just providing member service. Plans that treat Part D transition information as optional guidance, or that route it through a separate member services workflow that may not reach the member in time, are creating the conditions for the 63-day gap that triggers late enrollment penalties. The more important finding is that this is a compliance failure with a permanent member financial consequence, not merely a communication gap.
The Regulatory Framework: Two Pathways, Two Standards
A Medicare Advantage Prescription Drug (MAPD) plan integrates Part C (Medicare Advantage managed care) and Part D (prescription drug coverage) into a single product. When disenrollment occurs, it terminates both simultaneously. The two disenrollment pathways are legally distinct and governed by separate regulatory sections.
42 CFR 422.62: Voluntary Disenrollment
A statutory right exercisable only during CMS-designated enrollment periods: Annual Enrollment Period (October 15 to December 7, effective January 1), Open Enrollment Period (January 1 to March 31, effective first of following month), or a qualifying Special Enrollment Period. Plans that restrict, delay, or create friction in voluntary disenrollment requests are in violation of beneficiary rights requirements and subject to CMS enforcement.
42 CFR 422.74: Involuntary Disenrollment
A plan-initiated action permitted only on six enumerated grounds. The grounds are exhaustive, no other basis authorises removal. Required elements: advance written notice stating the specific ground and proposed effective date; the member’s right to appeal; and for disruptive behaviour cases, prior CMS approval before the effective date. A procedurally defective disenrollment is a regulatory violation even when the underlying ground is valid.
The Six Grounds for Involuntary Disenrollment Under 42 CFR 422.74
42 CFR 422.74 defines when an MA organisation may or must initiate disenrollment. The grounds are specific and exhaustive. Plans that process involuntary disenrollments on undocumented, informal, or unenumerated bases are in regulatory violation regardless of the operational justification offered.
Ground 1: Loss of Part A or Part B Entitlement
A beneficiary who loses entitlement to Medicare Part A or Part B is no longer eligible for Medicare Advantage. Disenrollment is required and takes effect aligned with the loss of entitlement. Plans must notify CMS promptly and inform the member of their coverage status and available options.
Ground 2: Permanent Move Outside Service Area
A member who permanently relocates outside the plan’s approved service area is no longer eligible for that plan. Plans should verify the move is permanent rather than temporary, temporary absence for travel, hospitalisation, or seasonal relocation does not meet this ground. The member gains a SEP to enrol in a plan covering their new location.
Ground 3: Non-Payment of Plan Premium
Where the plan charges a monthly premium, failure to pay after the required grace period permits disenrollment. CMS prescribes grace period and notice requirements. Plans must provide written notice before disenrolling for non-payment and must apply grace period rules consistently. Selective waiver of premiums for some members creates additional compliance exposure.
Ground 4: Fraud or Misrepresentation in Enrollment
Materially false information provided on the enrollment application may support disenrollment. This ground requires documented evidence of the misrepresentation, suspicion or discrepancies alone are not sufficient. Plans must follow notice and appeals procedures before the disenrollment takes effect and should involve compliance and legal review for each case.
Ground 5: Disruptive or Abusive Behaviour (Most Procedurally Demanding)
A member whose behaviour jeopardises the safety of plan staff or other enrollees may be disenrolled, but only after documented remediation attempts and with prior CMS approval before the effective date. This is the most procedurally demanding ground and the most frequent source of CMP exposure. Behaviour related to a disability is specifically protected: plans must demonstrate they could not reasonably accommodate the member before CMS will approve removal.
Ground 6: Plan Contract Non-Renewal or Termination
When CMS does not renew or terminates a plan’s contract, all enrolled members are disenrolled. This is a contract-level event, not a member-level removal. Affected members receive a SEP to join another plan without penalty. Plans must notify members within prescribed timeframes, including information about alternative plan options in the service area.
Grounds that never authorise involuntary disenrollment under any circumstances
High cost of care or frequency of healthcare utilisation, CMS explicitly prohibits removal for cost reasons
Health status, pre-existing condition, or disability, protected under Medicare’s non-discrimination framework
Failure to use in-network providers or follow care management recommendations
Non-compliance with disease management or wellness programme participation
Health status, pre-existing condition, or disability, protected under Medicare’s non-discrimination framework
Failure to use in-network providers or follow care management recommendations
Non-compliance with disease management or wellness programme participation
Notice Obligations and the Member Appeals Process
Before any involuntary disenrollment takes effect, 42 CFR 422.74 requires the MA organisation to provide written notice to the member. The notice must state the basis for the disenrollment, the proposed effective date, and the member’s right to appeal. A procedurally defective notice renders the disenrollment invalid even if the underlying ground is legitimate. Plans that skip or shorten the notice process to resolve an operational issue create liability exposure that exceeds the original problem.
Part D Coverage at Disenrollment: The Gap Most Plans Underestimate
When a beneficiary disenrols from a MAPD plan, the integrated Part D prescription drug coverage ends at the same moment as the Part C medical coverage. Members left without drug coverage may face late enrollment penalty accumulation under 42 CFR Part 423 if the gap extends beyond 63 days. Many beneficiaries do not understand this consequence, and many plan disenrollment processes fail to communicate it clearly.
| Disenrollment Type | Part D Coverage Status | Member’s Options for Continuity |
|---|---|---|
| Voluntary (AEP) | Ends December 31; new coverage begins January 1 | Enrol in new MAPD or standalone PDP effective January 1 during AEP |
| Voluntary (OEP) | Ends on effective disenrollment date | OEP does not create a standalone PDP window; member may face drug coverage gap |
| Involuntary (plan-initiated) | Ends on effective disenrollment date | SEP for involuntary loss of coverage applies; member may join MAPD or PDP |
| Plan contract termination | Ends when plan contract ends | CMS-designated SEP applies; plan must notify members in advance |
What This Means for Compliance Leaders
The evidence points to a consistent pattern: disenrollment compliance failures are operational and documentary, not primarily driven by intentional misuse of prohibited grounds. The implications for how compliance programmes should be structured are direct.
What compliance programmes typically get right
Staff know the six permissible grounds
Prohibited grounds (cost, health status) are trained
General disenrollment workflows exist
Annual compliance training covers the basics
Prohibited grounds (cost, health status) are trained
General disenrollment workflows exist
Annual compliance training covers the basics
Where audit findings consistently appear
Notice templates missing required elements
Ground documented verbally, not in writing
CMS approval not obtained for disruptive behaviour cases
Part D impact not communicated at disenrollment
No monthly monitoring against peer benchmarks
File records insufficient for audit review
Ground documented verbally, not in writing
CMS approval not obtained for disruptive behaviour cases
Part D impact not communicated at disenrollment
No monthly monitoring against peer benchmarks
File records insufficient for audit review
Practical Implications
Audit your notice templates before CMS does
Pull the current involuntary disenrollment notice template and confirm it contains: the specific ground, the proposed effective date, and the member’s right to appeal, in language that matches CMS-approved notice requirements. A template that omits any of these three elements is creating a regulatory violation on every use, regardless of whether the underlying ground is valid.
Build Part D impact language into every disenrollment communication
Every disenrollment communication, for both voluntary and involuntary pathways, must include a clear statement that integrated Part D coverage ends simultaneously, the member’s options for maintaining drug coverage, and the 63-day window before late enrollment penalties apply. This is not optional guidance, it is a compliance obligation under the integrated product framework.
Make disenrollment monitoring a standing compliance programme item
Track voluntary and involuntary disenrollment rates monthly against CMS-published plan peer data. Conduct quarterly file audits of a random sample of involuntary disenrollments. Review disenrollment-related grievances and appeals quarterly for patterns. Report findings to the Compliance Committee as a standing agenda item, not as an exception report that only surfaces when CMS identifies a problem first.
Treat disruptive behaviour cases as a compliance checkpoint, not an operations decision
Ground 5 (disruptive behaviour) is the highest-risk ground for CMP exposure because it requires prior CMS approval, documented remediation attempts, and a disability accommodation analysis before the effective date. Every case under this ground should be reviewed by compliance and legal before any action is taken, not after.
Executive Takeaway
- Disenrollment compliance risk is primarily procedural and documentary, most audit findings involve valid grounds processed without required documentation, proper notice, or file records sufficient for review.
- CMP exposure is per-member: a systematic notice deficiency affecting 50 disenrollments at $25,000 each represents $1.25 million in potential exposure before per-day sanctions apply.
- High voluntary disenrollment rates reduce Star Ratings and quality bonus eligibility, making disenrollment monitoring a financial performance issue, not just a compliance obligation.
- Part D coverage ends simultaneously with Part C at MAPD disenrollment; failure to communicate this at the point of disenrollment is a compliance failure with permanent member financial consequences.
- Ground 5 (disruptive behaviour) requires prior CMS approval before the effective date, the most common source of CMP exposure for involuntary disenrollments in operational practice.
Key Takeaways
Involuntary disenrollment is strictly enumerated, and strictly procedural
42 CFR 422.74 permits plan-initiated disenrollment on six grounds only. But using a valid ground without required notice, documentation, and, for Ground 5, prior CMS approval is still a regulatory violation. The ground is necessary but not sufficient.
Part D ends when MAPD ends, every time, for every member
The integrated Part D component terminates simultaneously with Part C coverage. Plans must communicate this at every disenrollment and provide members with information about SEPs and standalone PDP options. A 63-day gap means a permanent late enrollment penalty.
Disenrollment patterns are a compliance indicator, a quality measure, and a financial signal simultaneously
CMS reviews disenrollment data through three lenses at once: compliance (are the procedural requirements being met?), quality (is the plan retaining satisfied members?), and audit targeting (do irregular patterns suggest systemic programme failures?). Compliance teams that build disenrollment monitoring into their standing programme, monthly tracking, quarterly file audits, grievance review, are addressing all three simultaneously and catching programme failures before CMS does.
Frequently Asked Questions
What is the difference between voluntary and involuntary MAPD disenrollment?
Voluntary disenrollment is initiated by the member during a CMS-designated enrollment period (AEP, OEP, or qualifying SEP) under 42 CFR 422.62. Involuntary disenrollment is initiated by the plan under one of the six specific grounds in 42 CFR 422.74. The two pathways have different procedural requirements, notice obligations, and member appeal rights.
When can a MAPD member voluntarily disenroll from their plan?
Members may voluntarily disenroll during the Annual Enrollment Period (October 15 to December 7, effective January 1), the Open Enrollment Period (January 1 to March 31, effective first of following month), or during a qualifying Special Enrollment Period. Outside these windows, a qualifying SEP event is required. Plans may not restrict or delay voluntary disenrollment requests submitted during a valid enrollment period.
What are the six grounds for involuntary MAPD disenrollment?
Under 42 CFR 422.74, plans may initiate disenrollment when a member: (1) loses Part A or Part B entitlement, (2) permanently moves outside the service area, (3) fails to pay plan premiums within the grace period, (4) engaged in fraud or misrepresentation on the enrollment application, (5) exhibits disruptive behaviour after documented remediation attempts and with prior CMS approval, or (6) the plan’s CMS contract is not renewed or is terminated. No other ground is permissible.
Is written notice required before involuntary MAPD disenrollment?
Yes. 42 CFR 422.74 requires the plan to provide written notice to the member before any involuntary disenrollment takes effect. The notice must state the specific ground, the proposed effective date, and the member’s right to appeal. Plans that disenrol a member without proper advance written notice are in regulatory violation regardless of whether the underlying ground was valid. A procedurally defective notice invalidates the disenrollment.
What happens to Part D drug coverage when a member leaves a MAPD plan?
The integrated Part D prescription drug coverage terminates at the same time as the Part C coverage. Members must separately enrol in a standalone Prescription Drug Plan or another MAPD to maintain drug coverage. Members who are involuntarily disenrolled have a Special Enrollment Period to join another plan. A drug coverage gap exceeding 63 days may result in a permanent late enrollment penalty on future Part D premiums under 42 CFR Part 423.
Can a plan disenrol a member for high cost or frequent use of healthcare services?
No. CMS explicitly prohibits involuntary disenrollment based on the cost or frequency of a member’s healthcare utilisation, their health status, or any medical condition. These are not among the six permissible grounds in 42 CFR 422.74. A plan that removes a member for cost or utilisation reasons is in violation of Medicare’s non-discrimination requirements and is subject to CMS enforcement including Civil Monetary Penalties of up to $25,000 per member.
How should compliance teams monitor MAPD disenrollment patterns?
Track voluntary and involuntary disenrollment rates monthly and compare against CMS-published plan peer data each reporting cycle. Conduct quarterly file audits of a random sample of involuntary disenrollments: verify documented grounds, CMS-compliant notice, required approvals, and correct effective dates. Review disenrollment-related grievances and appeals quarterly and report findings to the Compliance Committee as a standing agenda item.
Sources
Government and Regulatory Sources
- 42 CFR 422.74: Disenrollment by the MA Organisation (eCFR): the governing regulation listing all permissible grounds, notice requirements, prohibited bases, and CMS approval requirements for involuntary disenrollment.
- 42 CFR 422.62: Election Process for Medicare Advantage (eCFR): enrollment and disenrollment election periods including AEP, OEP, and qualifying SEP provisions for voluntary disenrollment.
- 42 CFR 422.752: Basis for Civil Money Penalties (eCFR): the regulatory basis for CMS Civil Monetary Penalties including per-member penalty amounts for disenrollment violations of member rights.
- 42 CFR Part 423, Subpart B: Eligibility and Enrollment (eCFR): Part D enrollment and disenrollment rules including the late enrollment penalty framework for members who face drug coverage gaps at MAPD disenrollment.
- CMS Medicare Managed Care Manual, Chapter 2: Enrollment and Disenrollment: CMS operational guidance on MA enrollment and disenrollment procedures, notice requirements, effective date rules, and CMS approval requirements.
- CMS Medicare Advantage and Part D Enrollment Data (2024): source for Medicare Advantage plan enrollment figures, 33 million beneficiaries as of 2024, referenced in the statistical evidence section.
Research and Industry Sources
- CMS Medicare Prescription Drug Coverage General Information: guidance on Part D coverage, standalone PDP enrollment, and the interaction between MAPD and standalone drug plan rules at the point of disenrollment.
Related VelSafe Articles
Law
MAO/PDP Compliance Programs: What CMS Requires
CMS compliance programme requirements for Medicare Advantage organisations and Part D plan sponsors, including the seven core elements and mandatory oversight expectations.
Insights
Healthcare Fraud and Abuse: Enforcement Statistics and What They Mean
Annual enforcement data from HHS and DOJ, patterns that attract fraud investigations, and what compliance teams in managed care and Part D should monitor.
Law
Healthcare Plan Compliance Programme: Legal Requirements
The statutory and regulatory basis for healthcare compliance programme requirements, including the OIG guidance framework and how it applies to Medicare Advantage plan sponsors.
CMS COMPLIANCE INSIGHTS
Stay Ahead of CMS Compliance Requirements
VelSafe covers Medicare Advantage, Part D, and healthcare regulatory compliance in depth. Explore the full library for plan sponsors, compliance officers, and healthcare administrators.
Explore VelSafe Insights
